Capital Bank & Trust CO Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Capital Bank & Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$98.85 - $138.91 $6.75 Million - $9.48 Million	-68,262 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $72,884 - $116,362	1,108 Added 1.65%	68,262 $6.63 Million
Q1 2021 May 14, 2021	BUY	$64.07 - $91.75 $130,959 - $187,537	2,044 Added 3.14%	67,154 $4.59 Million
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $120,509 - $181,940	1,852 Added 2.93%	65,110 $5.58 Million
Q3 2020 Nov 13, 2020	BUY	$59.04 - $77.95 $44,693 - $59,008	757 Added 1.21%	63,258 $4.11 Million

Q2 2020 Aug 14, 2020	BUY	$29.01 - $74.23 $48,098 - $123,073	1,658 Added 2.73%	62,501 $4.57 Million
Q1 2020 May 15, 2020	BUY	$27.51 - $57.29 $1.67 Million - $3.49 Million	60,843 New	60,843 $2.07 Million

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.44B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.